Park, Sang Ki, Ph.D.

Assistant Professor
Department of Life Science
Division of Molecular and Life Sciences
Neurobiology

bar04_solid1x1_gray.gif

Publications Abstract     

E-mail

skpark@postech.ac.kr

Phone 

+82-54-279-2349(office)

Laboratory

Lab. of Molecular Neuro Psychiatry

bar04_solid1x1_black.gif

Profile |  Research Interests |  Selected Publications

bar04_solid1x1_black.gif

           

dia_red.gif Profile

2001

Ph.D. University of Virginia

2001-2006

Postdoctoral Research Fellow, Harvard Medical School/Howard Hughes Medical Institute

2006-2006

Postdoctoral Associate, Massachusetts Institute of Technology/Picower Institute of Learning and Memory ·

2004-2008

NARSAD Young Investigator

2006. 9

Dept. of Life Science, Postech

 

black01_up.gifTOP

 

     

dia_red.gif Research Interests

Mental illness such as mood disorders, schizophrenia and drug addiction is one of the most prevalent diseases in modern human society. However, the molecular mechanisms underlying pathogenesis of those diseases are largely unknown. Recently, the Molecular Psychiatry - molecular neurobiological study of psychiatric disorders - has emerged as a promising research domain of the modern neuroscience, rendering a unique approach to further understanding the pathogenesis of various psychiatric disorders. To this end, the Laboratory of Molecular NeuroPsychiatry (L.MNP) pursues in depth understanding of the molecular basis of psychiatric disorders, utilizing contemporary biochemical, molecular biological, cell biological, pharmacological, genetic and behavioral biological techniques. We believe that the research will not only expand our knowledge on higher brain functions such as cognition, emotion, mood, reward, and motivation but also allow identification of novel molecular targets for therapies against major psychiatric disorders. Current specific research directions in the lab are as following.

1. Modulation of dopamine receptor-mediated signaling
Dopamine is one of the most functionally prevalent neurotransmitters in the vertebrate brain. Its role in higher brain functions is mediated by five subtypes of dopamine receptors. Among them dopamine D2 receptor (D2DR) has been implicated in various psychiatric diseases including attention deficit hyperactivity disorder (ADHD), mood disorders, schizophrenia and drug addiction. Thus detailed understanding of D2DR-mediated signaling mechanisms is thought to provide platform for elucidation of those related psychiatric problems. The L.MNP is attempting to identify modulatory components in D2DR-mediated signaling in the context of higher brain functions and the pathogenesis of associated disorders.

2. Dopamine signaling and depression
Par-4 is a modulator of D2DR-mediated signaling. As a disruption of the normal function of Par-4 is associated with depression-like behaviors in a mouse model, it is thought to play a significant role in the pathways linking dopamine signaling and normal mood control. The L.MNP pursues further understanding of the neural function of Par-4 in relation to mood disorders, evaluating potentials as a molecular target for novel anti-depression therapies.

3. Molecular modeling of schizophrenia
Schizophrenia is a psychiatric disorder that is thought to have both neurochemical aspects (imbalances in dopamine, glutamate and GABA neurotransmission) and neurodevelopmental aspects (neuronal positioning, neuronal polarity and neurite outgrowth) in its pathogenesis. The complexity of the pathogenesis has hindered establishment of the genuine animal model reflecting schizophrenic condition. Recently, advances in human genetics provided candidates genes causative in the expression of schizophrenia. The L.MNP attempts to understand their physiological function to establish animal models useful to elucidate the molecular basis of schizophrenia.

black01_up.gifTOP

      

dia_red.gif Selected Publications

  1. Kim J, Park BH, Lee JH, Park SK, and Kim JH (2011),
    Cell type-specific alterations in the nucleus accumbens by repeated exposures to cocaine. Biol Psychiatry 69;1026-1034
  2. Chansard M, Wang J, Tran HC, Neumayer G, Shim SY, Park YU, Belzil C, Le HC, Park SK and Nguyen MD (2011),
    The Cytoskeletal Protein Ndel1 Regulates Dynamin 2 GTPase Activity. PLoS One 6(1):e14583.
  3. Park YU, Jeong J, Lee H, Mun JY, Kim JH, Lee JS, Nguyen MD, Han SS, Suh PG, and Park SK (2010),
    Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin.Proc Natl Acad Sci USA 107(41): 17785-90.    
  4. Lee S, Jeong J, Kwak Y, and Park SK (2010),
    Depression research: where are we now?. Mol Brain 3:8-17.
  5. Kim J, Jung SY, Lee YK, Park SK, Choi JS, Lee CJ, Kim HS, Choi YB, Scheiffele P, Bailey CH, Kandel ER, and Kim JH (2008),
    Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc Natl Acad Sci USA 105(26): 9087-9092.
  6. Park SK, George R, Cai Y, Chang HY, Krantz DE, Friggi-Grelin F, Birman S and Hirsh J (2006),
    Cell type-specific limitation on in vivo serotonin storage following ectopic expression of the Drosophila serotonin transporter, dSERT.J Neurobiol 66:452-62.
  7. Park SK, Nguyen MD, Fischer A, Affar EB, Luke MP, Dieffenbach PB, Tseng HC, Shi Y. and Tsai LH (2005),
    Par-4 links dopamine signaling and depression. Cell 122:275-287

black01_up.gifTOP

 

bar04_solid1x1_gray.gif

Division of Molecular & Life Sciences| POSTECH